204 related articles for article (PubMed ID: 16415903)
21. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
[TBL] [Abstract][Full Text] [Related]
22. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
24. ABIN-1 Negatively Regulates
Zhou P; Jiang J; Yan H; Li Y; Zhao J; Wang X; Su R; Gong Z
Mol Pharmacol; 2018 Feb; 93(2):36-48. PubMed ID: 29237725
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
Breivogel CS; Selley DE; Childers SR
J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
[TBL] [Abstract][Full Text] [Related]
26. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
27. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
Hosohata K; Burkey TH; Alfaro-Lopez J; Varga E; Hruby VJ; Roeske WR; Yamamura HI
Eur J Pharmacol; 1998 Apr; 346(1):111-4. PubMed ID: 9617760
[TBL] [Abstract][Full Text] [Related]
28. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists.
Yekkirala AS; Kalyuzhny AE; Portoghese PS
ACS Chem Neurosci; 2010 Feb; 1(2):146-54. PubMed ID: 22816017
[TBL] [Abstract][Full Text] [Related]
29. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
30. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.
Glass M; Northup JK
Mol Pharmacol; 1999 Dec; 56(6):1362-9. PubMed ID: 10570066
[TBL] [Abstract][Full Text] [Related]
31. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
[TBL] [Abstract][Full Text] [Related]
32. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
[TBL] [Abstract][Full Text] [Related]
33. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
Clark MJ; Linderman JJ; Traynor JR
Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
[TBL] [Abstract][Full Text] [Related]
34. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
[TBL] [Abstract][Full Text] [Related]
36. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
Gray RE; Munks MW; Haynes RR; Olsen GD
Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
[TBL] [Abstract][Full Text] [Related]
37. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
Hou Y; Tan Y; Belcheva MM; Clark AL; Zahm DS; Coscia CJ
Brain Res Dev Brain Res; 2004 Jul; 151(1-2):149-57. PubMed ID: 15246701
[TBL] [Abstract][Full Text] [Related]
39. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
[TBL] [Abstract][Full Text] [Related]
40. Mice Expressing Regulators of G protein Signaling-insensitive Gαo Define Roles of
Bouchet CA; McPherson KB; Li MH; Traynor JR; Ingram SL
Mol Pharmacol; 2021 Sep; 100(3):217-223. PubMed ID: 34135098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
